Trials / Terminated

TerminatedNCT00420706

Study Evaluating SCA-136 Tolerability With Dose Titration and Food

A Multi-Dose, Double-Blind, Parallel-Group Study of the Effects of Dose Titration and Administration With Food on the Tolerability of SCA-136 in Healthy Subjects

Status: Terminated
Phase: Phase 1
Study type: Interventional
Enrollment: 120 (planned)

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer · Industry
Sex: All
Age: 18 Years – 50 Years
Healthy volunteers: Accepted

Summary

To evaluate whether the tolerability of SCA-136 is improved by dosing with food or by increasing dose amounts in a step-wise fashion.

Conditions

Healthy

Interventions

Type	Name	Description
DRUG	SCA-136

Timeline

Start date: 2006-12-01
Completion: 2006-12-01
First posted: 2007-01-11
Last updated: 2007-12-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00420706. Inclusion in this directory is not an endorsement.